6 assets in Colorectal Adenoma

Therapeutic assets addressing Colorectal Adenoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Umbellatine Colorectal Adenoma	Jing-yuan Fang, MD, Ph. D	P2/3	B (61)
Aspirin Colorectal Adenoma	University of Edinburgh	P2	CCC (53)
Linaclotide Colorectal Adenoma	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	P2	CCC (53)
muc1 peptide-poly-iclc vaccine Colorectal Adenoma	National Cancer Institute (NCI)	P2	CCC (53)
Tirzepatide Colorectal Adenoma	Massachusetts General Hospital	P1	CC (43)
Metformin Colorectal Adenoma	University of Edinburgh	N/A	D (30)